Navigation Links
Site in Medical Technology
... percent of SIMPONI treated patients had injection site reactions compared with 2.2 percent in control-treated patients. The majority of the injection site reactions were mild and moderate, and the most frequent manifestation was injection site erythema.
For the Full U.S. ...
... percent and 1 percent of patients, and injection site reactions (ISR) through week 16 occurred in 3 ... nausea, abnormal liver tests, redness at site of injection, high blood pressure, bronchitis, ... company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com . ...
... experiencing serious adverse events. Injection site reactions occurred in eight percent of patients ... experiencing serious adverse events. Injection site reactions occurred in 11 percent of patients ... nausea, abnormal liver tests, redness at site of injection, high blood pressure, bronchitis, ...
... PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... SURGICAL IMPLANT for the prevention of surgical site infections. The trial is being conducted at ... considered to be the most prone to surgical site infection (SSI). Patients in the treatment group ... demonstrated a 70 percent decrease in surgical site infections from 18.4 percent in the control group ...
... SURGICAL IMPLANT for the prevention of surgical site infections. The trial is being conducted at ... tissue infections and the prevention of surgical site infections in both hard and soft tissues. ... trials in the U.S. for the prevention of surgical site infections and has received FDA fast-track ...
... PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... private databases, CPR analyzes each investigator site for multiple criteria to identify the optimal ... database, provides a powerful dataset for site selection and patient recruitment. "The clinical trials industry has repeatedly identified site initiation as a primary cause of delays," ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were mild ... no patient discontinued, and included injection site inflammation and reaction (i.e., bruise, ...
... how it can be prevented through vaccination. The site offers reporters, consumers and health-care ... service. By typing in their 5-digit zip code, site visitors can receive a list of immunization clinics in their area. site visitors may also schedule reminders and sign up ...
... (877-431-7763), or go to the Welchol web site at http://www.Welchol.com . About Daiichi ... s-treatment-familial-hypercholesterolemia.htm. site accessed September 19, 2008. (2) ... s-treatment-familial-hypercholesterolemia.htm. site accessed September 19, 2008. (4) American ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were ... (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving ...
... they cannot penetrate the nail and access the site of infection. The results were reported this ... dermis to more than 1 centimeter away from the site of application," said Susan Ciotti, Ph.D., ... because they are unable to penetrate to the site of infection. "The safe and efficient delivery ...
... of these molecules in the PDE4 enzymatic active site competitively with cAMP. As cAMP is of ... deCODE chemistry team to identify a novel binding site for allosteric modulators in the PDE4 regulatory domain. Binding of an allosteric modulator at that site is non-competitive with cAMP. DG071 has been ...
... adverse reaction was constipation. Application site reactions were reported but were mild and did not ... by the underlying condition. Mild application site reactions have occurred; remove patch if severe ... should avoid direct exposure of application site to natural or artificial sunlight by covering ...
... upper abdominal trocar placement that is often a site for significant patient discomfort. "This is a ... said Dr. Teixeira. "By reducing the operative site to one single incision in the belly button we are ... For more information, visit the company's web site at http://www.novaresurgical.com . ...
... to provide pain control directly at the surgical site and thus reduce the level of additional ... to provide continuous, long-term analgesia at the site of a surgical wound. Innocoll has already ... in post-operative pain, prevention of surgical site infection, and treatment of diabetic ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were ... (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving ...
... adverse events compared to placebo were injection site pain (5.1 percent vs. 20 percent), injection site burning (3.8 percent vs. 6.7 percent), dizziness ... indicated above, the reported rates of "injection site ...
... By acting at both the AMPA and kainate receptor site to competitively block the binding of glutamate, ... on the home page of TorreyPines Therapeutics' Web site at http://www.torreypinestherapeutics.com . ... available on TorreyPines Therapeutics' Web site until July 25. About TorreyPines Therapeutics ...
... swelling, bruising and pruritis at the injection site and transient lymph node swelling and pain. In ... be simultaneously web cast on Auxilium's web site and archived for future review until July 3, ... tab on the home page of the Company's web site at http://www . auxilium.com Web cast: ...
... of 40 ng/kg/min, infrequent subcutaneous catheter site changes, and proactive pain management. ... administration of Remodulin (e.g., infusion site pain), they tolerate treatment very well and ... of infusion. For subcutaneous infusion, infusion site pain and infusion site reaction (redness and ...
... adverse reactions vs. placebo were injection site reactions (20 percent vs. 14 percent), upper ... (17 percent vs. 13 percent), injection site pain (12 percent vs. 12 percent), headache (12 ... Medication Guide, is available on the Web site http://www.humira.com or in the United States ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were ... (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were ... (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving ...
... site accessed 4/18/2008 3. Kearney, P. et al. ... site accessed 4/18/2008 5. http://www.americanheart.org/presenter.jhtml?identifier=4621 site accessed 4/18/2008 ...
... infections and the prevention of surgical site infections in both hard and soft tissues; and is ... in the US for the prevention of surgical site infections. The development of the topical ... for the treatment and prevention of surgical site infections, is approved for sale in 49 countries ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were ... (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving ...
... percent and 1 percent of patients, and injection site reactions (ISR) through week 16 occurred in 3 ... nausea, abnormal liver tests, redness at site of injection, high blood pressure, bronchitis, ... company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com . ...
... experiencing serious adverse events. Injection site reactions occurred in eight percent of patients ... experiencing serious adverse events. Injection site reactions occurred in 11 percent of patients ... nausea, abnormal liver tests, redness at site of injection, high blood pressure, bronchitis, ...
FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
... Relations tab and are advised to go to the Web site at least 15 minutes early to register, download, ... The call will also be archived on the Vanda Web site for a period of 30 days, through June 6, 2009. ... are available free of charge at the SEC's web site at www.sec.gov or from Vanda at ...Transcept Pharmaceuticals to Report First Quarter 2009 Results
... from the Investors section on the corporate web site at www.transcept.com . A webcast replay can be accessed on the corporate web site beginning May 13, 2009 at the same time as the conference call and will remain on the site through May 27, 2009. About Transcept ...Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
... during degarelix therapy included injection site reactions (e.g. pain, erythema, swelling or ... Specifically relating to the injection site adverse reactions, most were transient, of mild ... (<1%). Grade 3 (severe) injection site reactions occurred in two percent or less of ...... PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... SURGICAL IMPLANT for the prevention of surgical site infections. The trial is being conducted at ... considered to be the most prone to surgical site infection (SSI). Patients in the treatment group ... demonstrated a 70 percent decrease in surgical site infections from 18.4 percent in the control group ...
... SURGICAL IMPLANT for the prevention of surgical site infections. The trial is being conducted at ... tissue infections and the prevention of surgical site infections in both hard and soft tissues. ... trials in the U.S. for the prevention of surgical site infections and has received FDA fast-track ...
... PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... private databases, CPR analyzes each investigator site for multiple criteria to identify the optimal ... database, provides a powerful dataset for site selection and patient recruitment. "The clinical trials industry has repeatedly identified site initiation as a primary cause of delays," ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were mild ... no patient discontinued, and included injection site inflammation and reaction (i.e., bruise, ...
... how it can be prevented through vaccination. The site offers reporters, consumers and health-care ... service. By typing in their 5-digit zip code, site visitors can receive a list of immunization clinics in their area. site visitors may also schedule reminders and sign up ...
... (877-431-7763), or go to the Welchol web site at http://www.Welchol.com . About Daiichi ... s-treatment-familial-hypercholesterolemia.htm. site accessed September 19, 2008. (2) ... s-treatment-familial-hypercholesterolemia.htm. site accessed September 19, 2008. (4) American ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were ... (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving ...
... they cannot penetrate the nail and access the site of infection. The results were reported this ... dermis to more than 1 centimeter away from the site of application," said Susan Ciotti, Ph.D., ... because they are unable to penetrate to the site of infection. "The safe and efficient delivery ...
ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
... - Multi-Center Study in Skin Graft Donor site Patients - ADDISON, Texas, Oct. 21 ... patients being enrolled. The first study site has been initiated and the Company plans to ... with Altrazeal(TM) Silver being applied to one site and the competitive dressing being applied to the ...Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
... improves their health and well-being. A new Web site from the National Institutes of Health (NIH), ... to enroll their child in a study." The Web site describes why research in children is important, ... and other conditions -- developed the Web site in collaboration with New England ...... of these molecules in the PDE4 enzymatic active site competitively with cAMP. As cAMP is of ... deCODE chemistry team to identify a novel binding site for allosteric modulators in the PDE4 regulatory domain. Binding of an allosteric modulator at that site is non-competitive with cAMP. DG071 has been ...
... adverse reaction was constipation. Application site reactions were reported but were mild and did not ... by the underlying condition. Mild application site reactions have occurred; remove patch if severe ... should avoid direct exposure of application site to natural or artificial sunlight by covering ...
... upper abdominal trocar placement that is often a site for significant patient discomfort. "This is a ... said Dr. Teixeira. "By reducing the operative site to one single incision in the belly button we are ... For more information, visit the company's web site at http://www.novaresurgical.com . ...
... to provide pain control directly at the surgical site and thus reduce the level of additional ... to provide continuous, long-term analgesia at the site of a surgical wound. Innocoll has already ... in post-operative pain, prevention of surgical site infection, and treatment of diabetic ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were ... (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving ...
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
... in the U.S. may have a tumor for which the site of origin is uncertain after the initial ... better decisions. "Knowing the primary tumor site with greater certainty enables more appropriate ... identification of the primary tumor site or tissue of origin. Targeting therapy to ...... adverse events compared to placebo were injection site pain (5.1 percent vs. 20 percent), injection site burning (3.8 percent vs. 6.7 percent), dizziness ... indicated above, the reported rates of "injection site ...
... By acting at both the AMPA and kainate receptor site to competitively block the binding of glutamate, ... on the home page of TorreyPines Therapeutics' Web site at http://www.torreypinestherapeutics.com . ... available on TorreyPines Therapeutics' Web site until July 25. About TorreyPines Therapeutics ...
... swelling, bruising and pruritis at the injection site and transient lymph node swelling and pain. In ... be simultaneously web cast on Auxilium's web site and archived for future review until July 3, ... tab on the home page of the Company's web site at http://www . auxilium.com Web cast: ...
... of 40 ng/kg/min, infrequent subcutaneous catheter site changes, and proactive pain management. ... administration of Remodulin (e.g., infusion site pain), they tolerate treatment very well and ... of infusion. For subcutaneous infusion, infusion site pain and infusion site reaction (redness and ...
... adverse reactions vs. placebo were injection site reactions (20 percent vs. 14 percent), upper ... (17 percent vs. 13 percent), injection site pain (12 percent vs. 12 percent), headache (12 ... Medication Guide, is available on the Web site http://www.humira.com or in the United States ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were ... (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving ...
Amikacin Inhale Shows Promising Results in Phase II Study
... shows that targeting antibiotic therapy to the site of infection might offer superior bacterial ... delivers the antibiotic directly to the site of infection, without reaching high systemic ... Inhale, which fights pneumonia directly at the site of infection, may be able to help decrease ...ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
... reduction in general disorders and administration site conditions when compared to Navelbine(R) ... entitled "Tolerability and incidence of infusion site reactions with emulsion formulation of ... of ADVENTRX. "The improvement in injection site reactions could translate into a real benefit ...... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were ... (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving ...
Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
... call 877-4-DSPROD (877-437-7763) or go to the web site http://www.azor.com . About Daiichi Sankyo, ... (5) http://www.cdc.gov/nchs/nhanes.htm site accessed 5/14/2008 (6) Chobanian, A.V., et al. ... site accessed 5/17/2007 (8) ...... site accessed 4/18/2008 3. Kearney, P. et al. ... site accessed 4/18/2008 5. http://www.americanheart.org/presenter.jhtml?identifier=4621 site accessed 4/18/2008 ...
Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests
... learn more about our organization, visit our Web site at: http://www.labcorp.com . (1) American Heart Association (AHA) 2008. Web site accessed Febuary 15, 2008: ... (2) World Health Organization (WHO) 2008. Web site accessed Feburary 15, 2008: ...Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
... TPM to deliver lidocaine (5%) to a targeted local site after a single topical application, while ... concentrations were measured in the skin at the site of application, as well as in the underlying ... concentrations were measured in the skin at the site of application, as well as in the underlying ...... infections and the prevention of surgical site infections in both hard and soft tissues; and is ... in the US for the prevention of surgical site infections. The development of the topical ... for the treatment and prevention of surgical site infections, is approved for sale in 49 countries ...
... however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were higher. ... in severity as treatment continues. Application site disorders were common (47%), but all were ... (i.e., bruise, itchiness, irritation). Injection site pain was reported in 2% of patients receiving ...
Other ContentsOther Tags
(Date:6/18/2013)... at the University of Calgary,s Faculty of Medicine have ... body from harmful bacteria. Platelets, a component of blood ... for specific bacteria, and upon detection, seal it off ... were published in Nature Immunology this week, ... immunity. , "The science community has known that platelets ...
(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...
(Date:6/18/2013)... Scientists are expecting a very large "dead zone" in ... hypoxic level in the Chesapeake Bay this year, based ... the University of Michigan, Louisiana State University, and the ... year,s Gulf of Mexico hypoxic "dead" zone will be ... it among the ten largest recorded. That would range ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4(Date:6/19/2013)... 19, 2013 Alternatives, a revolutionary new ... to quit using drugs while allowing them to continue ... founders of Alternatives, believe that abstinence-only approaches force people ... treatment and that this approach hurts instead of helping. ... the United States need treatment for addiction but only ...
(Date:6/19/2013)... Kansas City will host its first Ciclovia event on ... A section of Main Street in the midtown area will be ... event. The Main Street Corridor Development and BikeWalkKC ... City join the ranks of dozens of cities across the US ... community vibrancy and active lifestyles. , “Ciclovia is the perfect event ...
(Date:6/19/2013)... Bellingham, Washington (PRWEB) June 19, 2013 ... before physicians deem it medically necessary, according to ... Maternal and Child Health Journal. The results of ... advocating for more than a decade – that ... care, and maintaining a healthy body weight. Fairhaven ...
(Date:6/19/2013)... June 19, 2013 In 2011, the ... EUR 710 million. Generic drugs form the largest sector, ... value. The pharmaceutical industry is a significant contributor to ... the country’s GDP. Approximately 50% of the total domestic ... pharmaceutical industry. Hemofarm, Galenika and Zdravlje Actavis are key ...
(Date:6/19/2013)... today in Menopause International , suggests that ... and less satisfying sex compared to their European ... less likely to access appropriate treatment for a ... first-of-its-kind study, called the CLarifying vaginal atrophy,s impact ... British post-menopausal women with vaginal atrophy are more ...
Breaking Medicine News(10 mins):Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2Health News:British women 50 percent less likley to recieve treatment for common menopausal symptoms 2[0] Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment[0] Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia[0] Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies[0] Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com[0] British women 50 percent less likley to recieve treatment for common menopausal symptoms
ViewmaxOxiportFOCSPharyngoNasoHippleLaryngoscopesLaryngoscopeFastrachProSealLMAMedipreneSilkolatexFlange
Other Tags| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |